Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Operating Leases (2019 - 2025)

Historic Operating Leases for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $19.4 million.

  • Pulmonx's Operating Leases rose 463.58% to $19.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.4 million, marking a year-over-year increase of 463.58%. This contributed to the annual value of $18.5 million for FY2024, which is 157405.06% up from last year.
  • Latest data reveals that Pulmonx reported Operating Leases of $19.4 million as of Q3 2025, which was up 463.58% from $19.7 million recorded in Q2 2025.
  • Over the past 5 years, Pulmonx's Operating Leases peaked at $19.8 million during Q1 2025, and registered a low of $1.1 million during Q4 2023.
  • Moreover, its 5-year median value for Operating Leases was $8.8 million (2021), whereas its average is $10.5 million.
  • Per our database at Business Quant, Pulmonx's Operating Leases crashed by 7126.53% in 2023 and then soared by 157405.06% in 2024.
  • Pulmonx's Operating Leases (Quarter) stood at $6.8 million in 2021, then plummeted by 43.76% to $3.8 million in 2022, then plummeted by 71.27% to $1.1 million in 2023, then soared by 1574.05% to $18.5 million in 2024, then increased by 4.96% to $19.4 million in 2025.
  • Its Operating Leases was $19.4 million in Q3 2025, compared to $19.7 million in Q2 2025 and $19.8 million in Q1 2025.